Breaking News

ProJect Pharmaceutics Expands Safety Facilities

Adds labs dedicated to handle GMO S2 and BSL-2 based biologic products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ProJect Pharmaceutics (PJP), a company specializing in formulation and process development for parenteral drug products, has extended its safety facilities with laboratories dedicated to handle GMO S2 and BSL-2 based biologic products, such as live virus vaccines, protective and therapeutic vaccines, as well as gene and cell therapy products. The GMO S2 and BSL-2 safety lab is equipped with a dedicated pilot freeze dryer to design tailored lyophilization cycles. Also, analytical high-throughp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters